Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis
Authors:
- A. VercelliAVA. Vercelli
- O.M. MereutaOMO.M. Mereuta
- D. GarbossaD. Garbossa
- G. MuracaGMG. Muraca
- K. MareschiKMK. Mareschi
- D. RustichelliDRD. Rustichelli
- I. FerreroIFI. Ferrero
- L. MazziniLML. Mazzini
- E. MadonEME. Madon
- F. FagioliF. Fagioli
- 1 September 2008
- journal article
- Published by Elsevier in Neurobiology of Disease
- Vol. 31 (3) , 395-405
Abstract
No abstract availableKeywords
Funding Information
- Compagnia di San Paolo
This publication has 78 references indexed in Scilit:
- Targeted stem cell transplantation strategies in ALSNeurochemistry International, 2007
- Vascular Endothelial Growth Factor Overexpression Delays Neurodegeneration and Prolongs Survival in Amyotrophic Lateral Sclerosis MiceJournal of Neuroscience, 2007
- Neural differentiation potential of peripheral blood- and bone-marrow-derived precursor cellsBrain Research, 2006
- Amyotrophic Lateral Sclerosis — Are Microglia Killing Motor Neurons?New England Journal of Medicine, 2006
- Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemiaBrain, 2006
- Graft derived cells with double nuclei in the penumbral region of experimental brain traumaNeuroscience Letters, 2006
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Inflammatory processes in amyotrophic lateral sclerosisMuscle & Nerve, 2002
- From Marrow to Brain: Expression of Neuronal Phenotypes in Adult MiceScience, 2000
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993